Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-one brokerages that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and fifteen have given a buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $611.86.
ISRG has been the topic of a number of recent analyst reports. Robert W. Baird cut their price objective on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 18th. Truist Financial decreased their price target on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a research note on Monday, March 17th. Piper Sandler reissued an “overweight” rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Raymond James raised their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Finally, Citigroup upped their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th.
View Our Latest Stock Analysis on ISRG
Intuitive Surgical Stock Performance
Insider Activity at Intuitive Surgical
In other news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 33,754 shares of company stock worth $17,691,621. 0.70% of the stock is owned by company insiders.
Hedge Funds Weigh In On Intuitive Surgical
A number of hedge funds and other institutional investors have recently bought and sold shares of ISRG. Tounjian Advisory Partners LLC bought a new stake in shares of Intuitive Surgical during the first quarter worth approximately $5,152,000. Pallas Capital Advisors LLC boosted its holdings in shares of Intuitive Surgical by 2.1% in the 1st quarter. Pallas Capital Advisors LLC now owns 1,663 shares of the medical equipment provider’s stock valued at $824,000 after purchasing an additional 34 shares in the last quarter. Portside Wealth Group LLC raised its stake in Intuitive Surgical by 22.5% during the first quarter. Portside Wealth Group LLC now owns 1,661 shares of the medical equipment provider’s stock worth $823,000 after acquiring an additional 305 shares in the last quarter. Moss Adams Wealth Advisors LLC lifted its stake in Intuitive Surgical by 23.3% in the 1st quarter. Moss Adams Wealth Advisors LLC now owns 884 shares of the medical equipment provider’s stock valued at $438,000 after purchasing an additional 167 shares during the last quarter. Finally, NewSquare Capital LLC boosted its holdings in shares of Intuitive Surgical by 51.2% during the 1st quarter. NewSquare Capital LLC now owns 186 shares of the medical equipment provider’s stock valued at $92,000 after acquiring an additional 63 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Why NVIDIA Stock Could Soar Despite Wall Street Downgrades
- How to Profit From Growth Investing
- Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 Hot New IPOs Defying the 2025 Market Slump
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.